# Dihydroresveratrol

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/dihydroresveratrol
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** DHR, Dihydrostilbenol, 3,4',5-trihydroxy-dihydrostilbene, Dihydro-trans-resveratrol, Hydrogenated resveratrol, Dihydrostilbenoid

## Overview

Dihydroresveratrol is a reduced form of resveratrol that demonstrates enhanced bioavailability and stability compared to its parent compound. It activates AMPK and SIRT1 pathways to support cellular [energy metabolism](/ingredients/condition/energy) and [insulin sensitivity](/ingredients/condition/weight-management).

## Health Benefits

["\u2022 May support cellular energy balance by activating the AMP-activated protein kinase (AMPK) signaling pathway (preclinical evidence).[1]", "\u2022 May promote [insulin sensitivity](/ingredients/condition/weight-management) through the activation of downstream targets like SIRT1 (preclinical evidence).[1]", "\u2022 May inhibit adipogenesis (the formation of fat cells) via the AMPK pathway (preclinical evidence).[1]", "\u2022 May exert anti-inflammatory effects by inhibiting the NLRP3 inflammasome and reducing [pro-inflammatory cytokine](/ingredients/condition/inflammation)s like IL-1\u03b2 and IL-6 (preclinical evidence).[1]", "\u2022 May modulate cellular responses by activating the aryl hydrocarbon receptor (AHR) and inhibiting p38 MAPK (preclinical evidence).[1]"]

## Mechanism of Action

Dihydroresveratrol activates AMP-activated protein kinase (AMPK) signaling pathways, which regulate cellular energy homeostasis. It also stimulates [sirtuin](/ingredients/condition/longevity) 1 (SIRT1) deacetylase activity, promoting [mitochondrial biogenesis](/ingredients/condition/energy) and [glucose metabolism](/ingredients/condition/weight-management). The compound inhibits adipogenesis through modulation of PPAR-gamma and C/EBP transcription factors.

## Clinical Summary

Research on dihydroresveratrol is primarily limited to preclinical studies and cell culture models. Animal studies have shown improved glucose tolerance and reduced adipose tissue formation, but specific dosages and duration vary widely across studies. No large-scale human clinical trials have been conducted to establish therapeutic efficacy. The evidence base remains preliminary compared to its parent compound resveratrol.

## Nutritional Profile

Dihydroresveratrol (DHR) is a pure bioactive polyphenolic compound, not a whole food, and therefore does not contain macronutrients, vitamins, minerals, or fiber in the traditional nutritional sense. As a single molecule (C14H14O3, molecular weight ~230.26 g/mol), its profile is defined entirely by its chemical identity and bioavailability characteristics. It is a reduced metabolite of resveratrol, differing by the saturation of the 4,5-double bond in the stilbene backbone. Structurally, it retains two phenolic hydroxyl groups and one methoxy group, which contribute to its [antioxidant](/ingredients/condition/antioxidant) and signaling properties. Typical research and supplement doses range from 10–100 mg per administration in preclinical models; human dosing is not yet standardized. Bioavailability: DHR demonstrates notably improved oral bioavailability compared to its parent compound resveratrol, primarily because the saturated double bond renders it more resistant to rapid phase II [metabolism](/ingredients/condition/weight-management) (glucuronidation and sulfation) in the gut and liver. Studies suggest DHR achieves higher plasma concentrations and longer half-life than resveratrol at equivalent doses. It is lipophilic in nature (logP estimated ~2.5–3.0), meaning absorption is enhanced when taken with dietary fat. It is found endogenously as a gut microbiota-derived metabolite of resveratrol. No caloric value, protein, carbohydrate, fat, or micronutrient content is applicable to this compound in isolation.

## Dosage & Preparation

No clinically studied dosage ranges, forms, or standardization details for dihydroresveratrol have been established, as human trials are lacking. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for dihydroresveratrol in humans is limited due to the lack of clinical trials. Based on its structural similarity to resveratrol, potential interactions with anticoagulant medications and blood sugar-lowering drugs may occur. Pregnant and breastfeeding women should avoid supplementation due to insufficient safety data. Individuals with hormone-sensitive conditions should exercise caution as stilbenes may have estrogenic effects.

## Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses specifically investigating dihydroresveratrol were identified in the available research. All current evidence is derived from preclinical in vitro and animal models, and therefore no PMIDs for human studies are available.[1][2]

## Historical & Cultural Context

No historical or traditional medicinal uses for dihydroresveratrol are documented in the provided research. It is primarily known as a modern research compound and a metabolite of resveratrol, rather than an ingredient with a history of traditional use.[1][2]

## Synergistic Combinations

Resveratrol, Quercetin, Berberine, Curcumin, EGCG (from Green Tea)

## Frequently Asked Questions

### How does dihydroresveratrol differ from regular resveratrol?

Dihydroresveratrol is a hydrogenated form of resveratrol with enhanced stability and bioavailability. Unlike resveratrol, it resists degradation from light and heat, potentially offering more consistent absorption in the digestive tract.

### What is the optimal dosage of dihydroresveratrol?

No established human dosage exists for dihydroresveratrol due to limited clinical research. Preclinical studies have used doses ranging from 10-100 mg/kg body weight, but human equivalency and safety thresholds remain undetermined.

### Can dihydroresveratrol help with weight loss?

Preclinical studies suggest dihydroresveratrol may inhibit fat cell formation through AMPK activation and adipogenesis suppression. However, no human studies have confirmed weight loss effects or established effective dosing protocols.

### Does dihydroresveratrol activate the same longevity pathways as resveratrol?

Yes, dihydroresveratrol activates SIRT1 and AMPK pathways associated with longevity and cellular health. Some research suggests it may be more potent than resveratrol in activating these pathways due to improved bioavailability.

### Are there any side effects of dihydroresveratrol supplementation?

Specific side effects of dihydroresveratrol are unknown due to lack of human studies. Based on resveratrol research, potential effects may include digestive upset, headaches, and interactions with blood-thinning medications.

### What does clinical research show about dihydroresveratrol's effectiveness in humans?

Most evidence for dihydroresveratrol comes from preclinical studies in cell cultures and animal models, particularly demonstrating AMPK activation and insulin sensitivity improvements. Human clinical trials are limited, making it difficult to confirm whether the promising laboratory findings translate to meaningful health benefits in people. The existing research suggests potential, but larger-scale controlled studies in humans are needed to establish efficacy and optimal dosing strategies.

### Who would benefit most from taking dihydroresveratrol supplementation?

Individuals interested in metabolic health, insulin sensitivity, and cellular energy metabolism may be candidates for dihydroresveratrol, though clinical evidence in humans remains preliminary. People with metabolic concerns or those seeking to support AMPK activation pathways are commonly drawn to this ingredient based on preclinical research. However, anyone considering supplementation should consult a healthcare provider to assess whether it aligns with their specific health goals and circumstances.

### How does dihydroresveratrol's bioavailability compare to other resveratrol forms?

Dihydroresveratrol is the saturated, reduced form of resveratrol, which may offer improved stability and potentially better absorption in some contexts compared to standard resveratrol. The specific bioavailability advantage depends on the delivery formulation used (powder, liposomal, etc.) and individual digestive factors. Research directly comparing absorption rates between dihydroresveratrol and other resveratrol derivatives in human subjects remains limited.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*